[
| E-mail
]
Share
Contact: Jamie Brownjamie.brown@manchester.ac.uk
44-016-127-58383University of Manchester@UoMNews
Some patients with non-small cell lung cancer (NSCLC) have changes in the anaplastic lymphoma kinase (ALK) gene, which can drive the development of their cancer. A drug…
More evidence for impact of lung cancer targeted therapy from practice-changing trial
No comments:
Post a Comment